【科技日报】中国空间站完成空间生命科学在轨实验任务

Core Insights - The Tianzhou-9 cargo spacecraft successfully delivered 23 scientific experiments to the Chinese space station, with significant progress reported in life sciences experiments [1][2] - Three life science experiments involving liver cells, skeletal muscle precursor cells, and brain organoid chips have been completed, demonstrating the potential advantages of nucleic acid drugs in microgravity environments [1][2] Group 1: Life Sciences Experiments - The experiments have successfully achieved automated culture, in-orbit drug administration, microscopic imaging, and sample fixation [1] - In microgravity, the uptake efficiency of nucleic acid drugs by cells significantly increased, leading to a rapid decrease in disease-related protein expression levels, indicating superior therapeutic effects compared to ground control experiments [1][2] Group 2: Skeletal Muscle and Brain Research - Research on the impact of microgravity on skeletal muscle precursor cell migration indicates that migration is hindered, potentially affecting muscle regeneration and homeostasis [2] - The study using organ-on-a-chip technology shows that brain organoids can be cultured in 3D for extended periods in space, with faster neuronal migration observed compared to ground conditions [2] Group 3: Overall Scientific Achievements - As of August 22, 2025, the Chinese space station has implemented 58 scientific and application projects, conducting over 26,000 experiments and transporting more than 800 kilograms of scientific materials [2] - A total of 27 types of space science experiment samples have been returned, yielding 110 terabytes of scientific data [2]